AlphaQuest’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,207
Closed -$198K 1624
2025
Q4
$198K Sell
1,207
-1,884
-61% -$295K 0.01% 1451
2025
Q3
$413K Buy
3,091
+2,253
+269% +$274K 0.03% 925
2025
Q2
$104K Buy
+838
New +$107K 0.01% 1415
2024
Q4
Sell
-1,118
Closed -$166K 1959
2024
Q3
$166K Buy
+1,118
New +$160K 0.01% 1132
2024
Q2
Sell
-6
Closed -$1.1K 1834
2024
Q1
$1.1K Buy
+6
New +$1.14K ﹤0.01% 1363

Other funds holding RGEN

AlphaQuest's RGEN Position: Q1 2026 in Review

AlphaQuest sold out of Repligen (RGEN) in Q1 2026, closing a stake of 1,207 shares — an estimated $198K sold.

AlphaQuest first reported a position in RGEN in Q1 2024 and held it in 5 quarters. The position peaked at $413K in Q3 2025. 445 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • AlphaQuest reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 1,207 Repligen shares in Q1 2026, an estimated $198K.
  • AlphaQuest first reported a position in Repligen in Q1 2024 and held it in 5 quarters.
  • AlphaQuest's Repligen position peaked at $413K in Q3 2025.
  • 445 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.